Neuronal cell-based high-throughput screen for enhancers of mitochondrial function reveals luteolin as a modulator of mitochondria-endoplasmic reticulum coupling

[1]  Ronald L. Davis,et al.  High-Throughput Small Molecule Screen Identifies Modulators of Mitochondrial Function in Neurons , 2020, iScience.

[2]  V. Giorgio,et al.  Defective Mitochondrial Pyruvate Flux Affects Cell Bioenergetics in Alzheimer's Disease-Related Models. , 2020, Cell reports.

[3]  S. Ginés,et al.  Mitochondrial fission in Huntington's disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca2+ efflux and Reactive Oxygen Species (ROS) homeostasis , 2020, Neurobiology of Disease.

[4]  P. Stacpoole,et al.  The Changing Landscape of Clinical Trials for Mitochondrial Diseases: 2011 to Present. , 2020, Mitochondrion.

[5]  V. Weissig.  Drug Development for the Therapy of Mitochondrial Diseases. , 2019, Trends in molecular medicine.

[6]  K. Mikoshiba,et al.  IP3 receptor isoforms differently regulate ER-mitochondrial contacts and local calcium transfer , 2019, Nature Communications.

[7]  L. Zentilin,et al.  mCerulean3-Based Cameleon Sensor to Explore Mitochondrial Ca2+ Dynamics In Vivo , 2019, iScience.

[8]  K. Kang,et al.  Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells , 2019, Experimental & Molecular Medicine.

[9]  M. Hayden,et al.  Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model , 2019, Cell Death & Disease.

[10]  Subash C. Gupta,et al.  Health benefits of resveratrol: Evidence from clinical studies , 2019, Medicinal research reviews.

[11]  J. Sznajder,et al.  Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis. , 2019, Cell metabolism.

[12]  J. Sznajder,et al.  Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis. , 2019, Cell metabolism.

[13]  Sairam Krishnamurthy,et al.  Rebamipide Mitigates Impairments in Mitochondrial Function and Bioenergetics with α-Synuclein Pathology in 6-OHDA-Induced Hemiparkinson’s Model in Rats , 2019, Neurotoxicity Research.

[14]  C. Angelini,et al.  Regulation of ER‐mitochondria contacts by Parkin via Mfn2 , 2018, Pharmacological research.

[15]  G. Hassanzadeh,et al.  The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review , 2018, Journal of Molecular Neuroscience.

[16]  Focusing on mitochondrial form and function , 2018, Nature Cell Biology.

[17]  J. Ried,et al.  High throughput screening of mitochondrial bioenergetics in human differentiated myotubes identifies novel enhancers of muscle performance in aged mice , 2018, Scientific Reports.

[18]  M. Ankarcrona,et al.  TOM70 Sustains Cell Bioenergetics by Promoting IP3R3-Mediated ER to Mitochondria Ca2+ Transfer , 2018, Current Biology.

[19]  H. Vidal,et al.  Disruption of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Integrity Contributes to Muscle Insulin Resistance in Mice and Humans , 2018, Diabetes.

[20]  L. Scorrano,et al.  SPLICS: a split green fluorescent protein-based contact site sensor for narrow and wide heterotypic organelle juxtaposition , 2017, Cell Death & Differentiation.

[21]  David S. Park,et al.  Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases , 2017, Cell Death & Differentiation.

[22]  M. Hayden,et al.  Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice. , 2017, JCI insight.

[23]  Ying Zhao,et al.  Effects of luteolin on regulatory proteins and enzymes for myocyte calcium circulation in hypothermic preserved rat heart , 2017, Experimental and therapeutic medicine.

[24]  Lauren P. Wills.  The use of high-throughput screening techniques to evaluate mitochondrial toxicity. , 2017, Toxicology.

[25]  A. Kasahara,et al.  Mitochondrial dynamics coordinate cell differentiation. , 2017, Biochemical and biophysical research communications.

[26]  Michael J. Devine,et al.  α-Synuclein binds to the ER–mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production , 2017, Acta Neuropathologica.

[27]  P. Pizzo,et al.  The endoplasmic reticulum-mitochondria coupling in health and disease: Molecules, functions and significance. , 2017, Cell calcium.

[28]  Tongda Xu,et al.  Luteolin improves cardiac dysfunction in heart failure rats by regulating sarcoplasmic reticulum Ca2+-ATPase 2a , 2017, Scientific Reports.

[29]  Laura Contreras,et al.  Calcium regulation of mitochondrial carriers. , 2016, Biochimica et biophysica acta.

[30]  S. Saxena,et al.  Mitochondrial impairments contribute to Spinocerebellar ataxia type 1 progression and can be ameliorated by the mitochondria-targeted antioxidant MitoQ. , 2016, Free radical biology & medicine.

[31]  B. Bao,et al.  Dietary luteolin activates browning and thermogenesis in mice through an AMPK/PGC1α pathway-mediated mechanism , 2016, International Journal of Obesity.

[32]  A. Luini,et al.  Presenilin 2 Modulates Endoplasmic Reticulum-Mitochondria Coupling by Tuning the Antagonistic Effect of Mitofusin 2. , 2016, Cell reports.

[33]  Ja Hyun Koo,et al.  AMPK Facilitates Nuclear Accumulation of Nrf2 by Phosphorylating at Serine 550 , 2016, Molecular and Cellular Biology.

[34]  S. Cuzzocrea,et al.  Co-Ultramicronized Palmitoylethanolamide/Luteolin Promotes Neuronal Regeneration after Spinal Cord Injury , 2016, Front. Pharmacol..

[35]  L. Scorrano,et al.  Mitochondrial Cristae: Where Beauty Meets Functionality. , 2016, Trends in biochemical sciences.

[36]  R. Tian,et al.  Novel targets for mitochondrial medicine , 2016, Science Translational Medicine.

[37]  R. Balling,et al.  Characterization of Differentiated SH-SY5Y as Neuronal Screening Model Reveals Increased Oxidative Vulnerability , 2016, Journal of biomolecular screening.

[38]  A. Rego,et al.  Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington's disease mouse striatal cells , 2015, Neurochemistry International.

[39]  K. Francis,et al.  Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6 , 2015, Translational Psychiatry.

[40]  R. Chrast,et al.  Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration. , 2015, Brain : a journal of neurology.

[41]  J. Auwerx,et al.  A method to identify and validate mitochondrial modulators using mammalian cells and the worm C. elegans , 2014, Scientific Reports.

[42]  Xinyu Lu,et al.  Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE pathway. , 2014, Free radical biology & medicine.

[43]  L. Barbeito,et al.  Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis. , 2014, Free radical biology & medicine.

[44]  R. Phillips,et al.  Distinct structural features of TFAM drive mitochondrial DNA packaging versus transcriptional activation , 2014, Nature Communications.

[45]  P. Sanberg,et al.  Luteolin Reduces Alzheimer’s Disease Pathologies Induced by Traumatic Brain Injury , 2014, International journal of molecular sciences.

[46]  Christopher J. Chang,et al.  Preparation and use of MitoPY1 for imaging hydrogen peroxide in mitochondria of live cells , 2013, Nature Protocols.

[47]  A. Sugawara,et al.  The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus , 2013, Molecular and Cellular Biology.

[48]  E. Zintzaras,et al.  An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders. , 2013, Clinical therapeutics.

[49]  B. Winblad,et al.  Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models , 2013, Proceedings of the National Academy of Sciences.

[50]  S. Zeng,et al.  Interspecies difference of luteolin and apigenin after oral administration of Chrysanthemum morifolium extract and prediction of human pharmacokinetics. , 2013, Die Pharmazie.

[51]  T. Pozzan,et al.  Ca2+ dysregulation in neurons from transgenic mice expressing mutant presenilin 2 , 2012, Aging cell.

[52]  Werner J H Koopman,et al.  Monogenic mitochondrial disorders. , 2012, The New England journal of medicine.

[53]  N. Fineberg,et al.  Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress. , 2011, Free radical biology & medicine.

[54]  M. Brand,et al.  High Throughput Microplate Respiratory Measurements Using Minimal Quantities Of Isolated Mitochondria , 2011, PloS one.

[55]  B. Zhu,et al.  Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. , 2010, Free radical biology & medicine.

[56]  György Hajnóczky,et al.  Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. , 2010, Molecular cell.

[57]  Ming-Jiuan Wu,et al.  Neurotrophic and cytoprotective action of luteolin in PC12 cells through ERK-dependent induction of Nrf2-driven HO-1 expression. , 2010, Journal of agricultural and food chemistry.

[58]  R. Denton,et al.  Regulation of mitochondrial dehydrogenases by calcium ions. , 2009, Biochimica et biophysica acta.

[59]  Stuart L. Schreiber,et al.  Large-scale chemical dissection of mitochondrial function , 2008, Nature Biotechnology.

[60]  Teruo Hayashi,et al.  Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival , 2007, Cell.

[61]  P. Várnai,et al.  Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels , 2006, The Journal of cell biology.

[62]  Richard I. Morimoto,et al.  Progressive Disruption of Cellular Protein Folding in Models of Polyglutamine Diseases , 2006, Science.

[63]  H. Derendorf,et al.  Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans. , 2005, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[64]  T. Hagen,et al.  Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[65]  E. Simpson,et al.  Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. , 2003, Human molecular genetics.

[66]  James R. Burke,et al.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines , 2002, Nature Neuroscience.

[67]  Yuhui Liu,et al.  Sequential Treatment of SH‐SY5Y Cells with Retinoic Acid and Brain‐Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor‐Dependent, Human Neuron‐Like Cells , 2000, Journal of neurochemistry.

[68]  Z. Wei,et al.  Vitamin E regulates mitochondrial hydrogen peroxide generation. , 1999, Free radical biology & medicine.

[69]  T. Molinski,et al.  Xestospongins: Potent Membrane Permeable Blockers of the Inositol 1,4,5-Trisphosphate Receptor , 1997, Neuron.

[70]  P. Camilli.  Exocytosis goes with a SNAP , 1993, Nature.

[71]  W. T. Schaffer,et al.  The regulation of pyruvate oxidation during membrane depolarization of rat brain synaptosomes. , 1980, The Biochemical journal.

[72]  I. Ferreira,et al.  Assessing Mitochondrial Function in In Vitro and Ex Vivo Models of Huntington's Disease. , 2018, Methods in molecular biology.

[73]  Ricardo Macarrón,et al.  Design and Implementation of High Throughput Screening Assays , 2011, Molecular biotechnology.

[74]  F. Witzmann,et al.  Synaptosome proteomics. , 2007, Sub-cellular biochemistry.

[75]  G. Fuhrmann,et al.  Luteolin protects rat PC12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway. , 2007, Journal of neural transmission. Supplementum.

[76]  Chih-Hung Hsu,et al.  Clinical studies with curcumin. , 2007, Advances in experimental medicine and biology.

[77]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..